HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mimics of cholangiocarcinoma: spectrum of disease.

Abstract
Cholangiocarcinoma is the second most common primary malignant hepatobiliary neoplasm, accounting for approximately 15% of liver cancers. Diagnosis of cholangiocarcinoma is challenging and the prognosis is uniformly poor, with recurrence rates of 60%-90% after surgical resection. A wide spectrum of neoplastic and nonneoplastic conditions of the biliary tract may masquerade as cholangiocarcinoma, adding to the complexity of management in patients suspected to have cholangiocarcinoma. Mimics of cholangiocarcinoma constitute a heterogeneous group of entities that includes primary sclerosing cholangitis, recurrent pyogenic cholangitis, acquired immunodeficiency syndrome cholangiopathy, autoimmune pancreatitis, inflammatory pseudotumor, Mirizzi syndrome, xanthogranulomatous cholangitis, sarcoidosis, chemotherapy-induced sclerosis, hepatocellular carcinoma, metastases, melanoma, lymphoma, leukemia, and carcinoid tumors. These entities demonstrate characteristic histomorphology and variable clinicobiologic behaviors. The imaging findings of these disparate entities are protean and may be indistinguishable from those of cholangiocarcinoma. In most cases, a definitive diagnosis can be established only with histopathologic examination of a biopsy specimen.
AuthorsChristine O Menias, Venkateswar R Surabhi, Srinivasa R Prasad, Hanlin L Wang, Vamsi R Narra, Kedar N Chintapalli
JournalRadiographics : a review publication of the Radiological Society of North America, Inc (Radiographics) 2008 Jul-Aug Vol. 28 Issue 4 Pg. 1115-29 ISSN: 1527-1323 [Electronic] United States
PMID18635632 (Publication Type: Journal Article, Review)
Topics
  • Bile Duct Neoplasms (diagnosis)
  • Bile Ducts, Intrahepatic (diagnostic imaging, pathology)
  • Carcinoma (diagnosis)
  • Cholangiocarcinoma (diagnosis)
  • Diagnosis, Differential
  • Female
  • Humans
  • Liver Neoplasms (diagnosis)
  • Male
  • Radiography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: